Regulation and functions of non-m6A mRNA modifications

H Sun, K Li, C Liu, C Yi - Nature Reviews Molecular Cell Biology, 2023 - nature.com
Nucleobase modifications are prevalent in eukaryotic mRNA and their discovery has
resulted in the emergence of epitranscriptomics as a research field. The most abundant …

Detection technologies for RNA modifications

Y Zhang, L Lu, X Li - Experimental & Molecular Medicine, 2022 - nature.com
To date, more than 170 chemical modifications have been characterized in RNA, providing a
new layer of gene expression regulation termed the 'epitranscriptome'. RNA modification …

Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI

C Liu, H Sun, Y Yi, W Shen, K Li, Y ** DNA and RNA modifications
Y Kong, EA Mead, G Fang - Nature Reviews Genetics, 2023 - nature.com
Chemical modifications to nucleic acids occur across the kingdoms of life and carry
important regulatory information. Reliable high-resolution map** of these modifications is …

Regulation of gene expression by m6Am RNA modification

B Cesaro, M Tarullo, A Fatica - International Journal of Molecular …, 2023 - mdpi.com
The field of RNA modification, also referred to as “epitranscriptomics,” is gaining more and
more interest from the scientific community. More than 160 chemical modifications have …

Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants

R Vaid, A Mendez, K Thombare… - Genome …, 2023 - genome.cshlp.org
Insights into host–virus interactions during SARS-CoV-2 infection are needed to understand
COVID-19 pathogenesis and may help to guide the design of novel antiviral therapeutics. N …

The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma

K Li, J Chen, C Zhang, M Cheng… - The Journal of …, 2023 - Am Soc Clin Investig
PCIF1 can mediate the methylation of N 6, 2′-O-dimethyladenosine (m6Am) in mRNA. Yet,
the detailed interplay between PCIF1 and the potential cofactors and its pathological …

[HTML][HTML] Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification

Y Zhao, S Wen, H Li, CW Pan, Y Wei, T Huang, Z Li… - Theranostics, 2023 - ncbi.nlm.nih.gov
Rationale: Prostate cancer metastasizes to the bone with the highest frequency and exhibits
high resistance to 177 Lu-prostate-specific membrane antigen (PSMA) radioligand therapy …